Abstract
Infection remains one of the leading causes of failure in cemented orthopedic implants, particularly in healthcare systems with limited access to imported formulations offering diverse antibiotic options. This study evaluates a commercially available Brazilian poly(methyl methacrylate) (PMMA) bone cement loaded with gentamicin and vancomycin (0.625–2.5 wt%, alone or in combination) to identify concentrations that balance mechanical integrity, antimicrobial efficacy, drug release, and cytocompatibility. Compressive strength, density, differential scanning calorimetry (DSC), scanning electron microscopy with energy-dispersive spectroscopy (SEM/EDS), antibiotic release, antibacterial activity, and cytocompatibility were assessed. All antibiotic-containing formulations maintained compressive strength ≥82 MPa, complying with ISO 5833 (control ≈110 MPa). SEM/EDS analyses revealed increased porosity and surface heterogeneity in the presence of antibiotics, more pronounced with vancomycin. Gentamicin or vancomycin at 2.5 wt% completely eradicated both bacterial strains, whereas the equimolar low-dose combination (0.625% + 0.625%) achieved comparable logarithmic reductions with substantially lower total drug content. Release profiles demonstrated rapid vancomycin elution and sustained gentamicin delivery, enabling an early-to-prolonged antibacterial effect. All formulations preserved cell viability above 80%, in accordance with ISO 10993-5. The low-dose gentamicin/vancomycin combination represents a promising strategy to achieve effective local antimicrobial activity while maintaining mechanical performance and cytocompatibility.